Gingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries

Last updated: February 8, 2025
Sponsor: Misr International University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Periodontitis

Treatment

Connective tissue graft

Non surgical

Free gingival graft

Clinical Study ID

NCT05688293
PER 5213005
  • Ages 18-55
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Thin gingival phenotype is one of the major causative factors of gingival recession type 1 which can result in hypersensitivity, discomfort, and compromised esthetics. This study assess the efficacy of increasing the gingival thickness from thin gingival phenotype to thick gingival phenotype in the treatment of patients suffering from gingival recession (RT1) and maintenance of results using either connective tissue graft or de-epithelized free gingival graft after non-surgical periodontal debridement compared to non-surgical periodontal debridement alone.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Medically free patients (American Society of Anesthesiologists I; ASA I)

  • Patients diagnosed with recession (RT1)

  • Fair oral hygiene

  • Patient accepting to provides an informed consent and the follow-up

Exclusion

Exclusion Criteria:

  • Carious teeth and teeth with periapical infection.

  • Patients diagnosed with periodontitis

  • Smokers

  • Pregnant and lactating females

Study Design

Total Participants: 30
Treatment Group(s): 3
Primary Treatment: Connective tissue graft
Phase:
Study Start date:
February 05, 2025
Estimated Completion Date:
March 01, 2026

Study Description

This parallel arm randomized controlled clinical trial study will include systematically free patients with thin gingival phenotype. They will be randomly allocated to three equal groups. Group A (test group, n=10) will receive non-surgical periodontal treatment and connective tissue graft using tunneling technique, Group B (test group, n=10) will receive non-surgical periodontal treatment and partially de-epithelized free gingival graft, while group C (control group, n=10) will receive non-surgical periodontal treatment only. After 3, 6 and 12 months gingival biotype will be clinically assessed (1ry outcome). This parameter will be recorded at baseline, 3, 6 and 12 months. The 2ry outcomes will include recording of recession depth, plaque index, bleeding on probing, keratinized tissue width . Postoperative pain and swelling will be recorded daily by the patient for the 1st two weeks post-surgically. Postoperative instructions and medication will be given to the patient. All readings will be carried out by a calibrated outcome assessor who will be masked. Follow-up will be performed to assess the outcomes and to ensure performing proper oral hygiene. Data collected will be tabulated and statistically analyzed.

Connect with a study center

  • Faculty of oral and dental medicine, Misr international university

    Cairo, 12345
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.